Abcam Plc Results for the 12- and 18-month periods ended 31 December 2021
14 mars 2022 08h00 HE
|
Abcam
Growing demand for Abcam’s portfolio of in-house products drives calendar 2021 revenues up by 22% at constant exchange rates Acquisition of BioVision completed 26 October 2021 CAMBRIDGE, United...
29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases
13 sept. 2021 07h00 HE
|
Abcam
CAMBRIDGE, United Kingdom, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research...
Abcam to Acquire BioVision for $340 million
02 août 2021 02h00 HE
|
Abcam
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research...
Abcam and MEDx extend precision medicine strategic partnership
12 avr. 2021 05h00 HE
|
Abcam
Building on existing three-year collaborationFocusing on co-development of companion and in vitro diagnostic kits to support demand in China CAMBRIDGE, United Kingdom and SHANGHAI, China, April 12,...
Abcam Wins Industry Awards from CiteAb
24 mars 2021 07h49 HE
|
Abcam
CAMBRIDGE, United Kingdom, March 24, 2021 (GLOBE NEWSWIRE) -- Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced that Dr Alejandra Solache, SVP of...
8.3% constant currency revenue growth in H1 as customers gradually return to labs
08 mars 2021 07h00 HE
|
Abcam
CAMBRIDGE, United Kingdom, March 08, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (“Abcam”, the “Group” or the “Company”), a global leader in the supply of life science research...
Abcam Expands Presence in China to Support Increased Demand of BioPharma Sector
04 mars 2021 04h00 HE
|
Abcam
Scaling up R&D, manufacturing and commercial capabilities in Shanghai and Hangzhou Investing in state-of-the-art facilities and equipment to support research, diagnostic and clinical applications ...
Abcam to Report Interim Results on Monday, March 8, 2021
26 févr. 2021 02h00 HE
|
Abcam
CAMBRIDGE, United Kingdom, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam” or the “Company”), a global leader in the supply of life science research tools, will report...
Abcam to present at the 2021 SVB Leerink Global Healthcare Conference
17 févr. 2021 07h00 HE
|
Abcam
CAMBRIDGE, United Kingdom, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; LSE: ABC) today announced that Alan Hirzel, Chief Executive Officer, will present at the 2021 SVB Leerink Global...
Abcam Plc Appointment of Non-Executive Directors
28 janv. 2021 02h00 HE
|
Abcam
CAMBRIDGE, United Kingdom, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam”), a global leader in the supply of life science research tools, is delighted to announce the...